Matches in Wikidata for { <http://www.wikidata.org/entity/Q91283033> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q91283033 description "article scientifique (publié 2019)" @default.
- Q91283033 description "articolo scientifico (pubblicato il 2019)" @default.
- Q91283033 description "artikull shkencor i botuar më 01 janar 2019" @default.
- Q91283033 description "artículu científicu espublizáu en xineru de 2019" @default.
- Q91283033 description "im Januar 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91283033 description "scientific article published on 01 January 2019" @default.
- Q91283033 description "wetenschappelijk artikel" @default.
- Q91283033 description "наукова стаття, опублікована 1 січня 2019" @default.
- Q91283033 description "научна статия" @default.
- Q91283033 name "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 name "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 name "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 type Item @default.
- Q91283033 label "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 label "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 label "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 prefLabel "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 prefLabel "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 prefLabel "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 P1433 Q91283033-F874E4A3-84C1-4835-A7A4-D57C320279CE @default.
- Q91283033 P1476 Q91283033-87CD8270-60CE-42C3-BC01-A86009B5511A @default.
- Q91283033 P2093 Q91283033-07369949-33F6-479D-9E07-B87EA1296B13 @default.
- Q91283033 P2093 Q91283033-42F2B1B0-0054-4126-8E45-7B31C1319A75 @default.
- Q91283033 P2093 Q91283033-56D6B1D8-219E-43EF-A38F-CFDF68A8DF36 @default.
- Q91283033 P2093 Q91283033-58CBDBC1-8AE9-455C-9785-761BC64D2194 @default.
- Q91283033 P2093 Q91283033-9D65BF97-00AD-4A22-AA12-053599F93360 @default.
- Q91283033 P2093 Q91283033-9F4D2AFB-D9C7-4135-A9DF-1E8110700EAE @default.
- Q91283033 P2093 Q91283033-B3975B4A-4268-417E-8FEB-0C784D6DBAC5 @default.
- Q91283033 P2093 Q91283033-EC414EEA-313B-4B0F-894A-BA80CA2BC071 @default.
- Q91283033 P31 Q91283033-5723CE57-CE8A-43F2-A219-F55D1004AE9A @default.
- Q91283033 P356 Q91283033-98B48357-F5C4-4A71-B702-B22E8CC0EE79 @default.
- Q91283033 P433 Q91283033-4DB4A9F3-24E6-42C7-81A7-E10D3A7DDB94 @default.
- Q91283033 P478 Q91283033-07FD2B11-71FF-4490-9C41-9F4F04B57CC9 @default.
- Q91283033 P50 Q91283033-54583FE6-D214-461D-A40F-592D5848E198 @default.
- Q91283033 P50 Q91283033-93460FBE-5805-4FF6-B7E3-3BC54EBD83F4 @default.
- Q91283033 P50 Q91283033-AA53796A-355D-4EBE-8470-AA200977D2DC @default.
- Q91283033 P50 Q91283033-B9C84531-0135-45CF-AE8A-8D2AC8549D5F @default.
- Q91283033 P50 Q91283033-BACFC177-B42F-4263-85B5-FEB68F1D377F @default.
- Q91283033 P50 Q91283033-FAE054F2-A5DF-4FE3-BE8E-7272B3997401 @default.
- Q91283033 P577 Q91283033-9FBC235E-A5D2-4F92-BB9E-ED2D8605AB9B @default.
- Q91283033 P698 Q91283033-50ED7B64-E740-4E5C-80F5-61971178FFA6 @default.
- Q91283033 P921 Q91283033-2717BE9C-6C6C-4949-8CF2-83A0C23CE30C @default.
- Q91283033 P356 SCITRANSLMED.AAT7973 @default.
- Q91283033 P698 30700576 @default.
- Q91283033 P1433 Q1573955 @default.
- Q91283033 P1476 "A biologic scaffold-associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy" @default.
- Q91283033 P2093 "Benjamin V Park" @default.
- Q91283033 P2093 "Christopher Cherry" @default.
- Q91283033 P2093 "Drew M Pardoll" @default.
- Q91283033 P2093 "Guannan Wang" @default.
- Q91283033 P2093 "Matthew T Wolf" @default.
- Q91283033 P2093 "Radhika Narain" @default.
- Q91283033 P2093 "Saraswati Sukumar" @default.
- Q91283033 P2093 "Tony L Wang" @default.
- Q91283033 P31 Q13442814 @default.
- Q91283033 P356 "10.1126/SCITRANSLMED.AAT7973" @default.
- Q91283033 P433 "477" @default.
- Q91283033 P478 "11" @default.
- Q91283033 P50 Q37837626 @default.
- Q91283033 P50 Q48472953 @default.
- Q91283033 P50 Q88258658 @default.
- Q91283033 P50 Q91283024 @default.
- Q91283033 P50 Q91283027 @default.
- Q91283033 P50 Q91283029 @default.
- Q91283033 P577 "2019-01-01T00:00:00Z" @default.
- Q91283033 P698 "30700576" @default.
- Q91283033 P921 Q1427096 @default.